MONOKET Drug Patent Profile
✉ Email this page to a colleague
When do Monoket patents expire, and what generic alternatives are available?
Monoket is a drug marketed by Omnivium Pharms and is included in one NDA.
The generic ingredient in MONOKET is isosorbide mononitrate. There are thirty-seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Monoket
A generic version of MONOKET was approved as isosorbide mononitrate by CHARTWELL MOLECULAR on October 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MONOKET?
- What are the global sales for MONOKET?
- What is Average Wholesale Price for MONOKET?
Summary for MONOKET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 4,076 |
What excipients (inactive ingredients) are in MONOKET? | MONOKET excipients list |
DailyMed Link: | MONOKET at DailyMed |
US Patents and Regulatory Information for MONOKET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omnivium Pharms | MONOKET | isosorbide mononitrate | TABLET;ORAL | 020215-002 | Jun 30, 1993 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Omnivium Pharms | MONOKET | isosorbide mononitrate | TABLET;ORAL | 020215-001 | Jun 30, 1993 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |